This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Pharmacy and Prescription Drugs – News

News stories from the past 60 days.

Aug 21, 2025 - Notice of interim final rule from the U.S. Department of Health and Human Services (HHS) updating compliance and other dates in the December 13, 2024, final rule to conform with the delay of effective date changes finalized in the February 11, 2025, final rule. This rule is effective August 20, 2025. Compliance with the December 2024 rule is required by April 14, 2028.
Source: Federal Register
Aug 7, 2025 - Notice from the Health Resources and Services Administration (HRSA) correcting the August 1, 2025, announcement of the application process for the 340B Rebate Model Pilot Program and call for comments related to the structure and application process of the program. Drug manufacturer plans for participation in the 340B Rebate Model Pilot Program should be submitted 340BPricing@hrsa.gov by September 15, 2025. The program will start January 1, 2026, and run for 1 year. Comments are due September 8, 2025.
Source: Federal Register
Aug 7, 2025 - Notice from the Health Resources and Services Administration (HRSA) seeking comments on an information collection request titled "Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program, OMB No. 0915-0327—Revision." HRSA requires covered entities to submit administrative information, certifying information, and attestation from appropriate grantee-level or entity-level authorizing officials and primary contacts in order to enroll and certify the eligibility of federally funded grantees and other safety net health care providers. Comments are due by October 6, 2025.
Source: Federal Register
Aug 1, 2025 - Announcement of the application process for the 340B Rebate Model Pilot Program and call for comments related to the structure and application process of the program. This program is voluntary and aims to test a rebate model on a select group of drugs for the purpose of understanding the merits and shortcomings of the rebate model. Drug manufacturers interested in participating should email 340BPricing@hrsa.gov by September 15, 2025. The program will start January 1, 2026 and run for 1 year. Comments are due September 2, 2025.
Source: Federal Register
Jul 14, 2025 - The Centers for Medicare and Medicaid Services is seeking comments on the following information collections: 1) The PACE Organization (PO) Monitoring and Audit Process; and 2) Creditable Coverage Disclosure to CMS On-Line Form and Instructions. Comments are due by August 13, 2025.
Source: Federal Register
Jun 24, 2025 - Announces new requirements for HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by health centers through the 340B Drug Pricing Program.
Source: Health Resources & Services Administration
Last Updated: 8/21/2025